Citations

Mayo Clinic

Showing 10 of 108602 citations.

Prognostic implications of Q waves at presentation in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS‐AMI study
Kosmidou, Ioanna , Redfors, Björn , Crowley, Aaron , Dizon, José , Embacher, Monica, Ben‐Yehuda, Ori , Mintz, Gary S. , Stone, Gregg W. , Gersh, Bernard J. , Chen, Shmuel , Mehran, Roxana

Clinical Cardiology | July 11, 2017 | Volume: 40 | Issue: 11 | Pages: 982-987

10.1002/clc.22751 | PMID 28696573 Get It

BackgroundPresence of Q waves on the presenting electrocardiogram (ECG) in patients with ST‐segment elevation myocardial infarction (STEMI) has been associated with worse prognosis; however, whether the prognostic value of Q waves is influenced by baseline characteristics and/or rapidity of revascularization based on the guideline‐based metric of door‐to‐balloon time remains unknown.HypothesisWe hypothesized that Q waves in the presenting ECG will be predictive of long term mortality regardless of time to reperfusion.MethodsThe Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) trial enrolled 3602 patients with STEMI undergoing primary percutaneous coronary intervention. We stratified patients without prior history of myocardial infarction or coronary revascularization according to presence or absence of pathological Q waves on their presenting ECG. Associations between Q waves, death, and cardiovascular outcomes within 3 years were assessed using Cox proportional hazards regression.ResultsAmong 2723 patients with evaluable ECGs, 1084 (39.8%) had Q waves on their presenting ECG. Male sex and time from symptom onset to balloon inflation were independent predictors of presence of Q waves. Patients with Q waves had higher adjusted risks of all‐cause death (adjusted hazard ratio: 1.45, 95% confidence interval: 1.02‐2.05, P = 0.04) and cardiac death (adjusted hazard ratio: 1.72, 95% confidence interval: 1.08‐2.72, P = 0.02). The association between Q waves and cardiac death was consistent regardless of sex, diabetes status, target vessel, or door‐to‐balloon time (Pinteraction > 0.4 for all).ConclusionsPresence of Q waves on the presenting ECG in patients undergoing primary percutaneous coronary intervention due to STEMI is an independent predictor of mortality and adds prognostic value, regardless of sex or rapidity of revascularization.
Imaging of Pregnancy-related Vascular Complications
Plowman, R. Scooter , Javidan-Nejad, Cylen, Raptis, Constantine A. , Katz, Douglas S. , Mellnick, Vincent M. , Menias, Christine O. , Bhalla, Sanjeev , Cornejo, Patricia , Mellnick, Vincent

RadioGraphics | July 11, 2017 | Volume: 37 | Issue: 4 | Pages: 1270-1289

10.1148/rg.2017160128 | PMID 28696852 Get It

Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long‐term institutional experience with chemotherapy, surgery, and dose‐ and field‐adapted radiotherapy
Breen, William G. , Blanchard, M.J., Rao, Amulya Nageswara, Buckner, Jan C. , Laack, Nadia N. , Laack, Nadia N Issa , Rao, Amulya A. Nageswara , Daniels, David J.

Pediatric Blood & Cancer | July 11, 2017 | Volume: 64 | Issue: 11 | Pages: No page available

10.1002/pbc.26637 | PMID 28695992 Get It

AbstractPurposeTo evaluate patterns of failure after multimodality treatment of nongerminomatous germ cell tumors (NGGCTs).Materials and methodsWe retrospectively reviewed records of 34 patients diagnosed with primary intracranial NGGCT between 1988 and 2014.ResultsThirty‐four patients received induction chemotherapy followed by radiation with or without surgery. Median follow‐up was 11.1 years (0.8–23.3). Outcomes were significantly improved in these 34 patients (5‐year overall survival [OS]: 88% versus 50%, P = 0.0092), so analysis is restricted to that subset. Disease‐free survival (DFS) was 67, 60, and 54% at 5, 10, and 15 years, respectively. Elevated cerebrospinal fluid–α‐fetoprotein (CSF–AFP) at diagnosis was associated with poorer DFS (37 vs. 89% at 10 years; P = 0.01). There was no statistically significant difference in OS, or DFS, or patterns of failure for limited radiotherapy volumes versus larger volumes; however, patients receiving initial local radiotherapy had 32% distant central nervous system (CNS) recurrence at 10 years compared to 0% for those receiving initial larger field irradiation (P = 0.09). Fifteen patients recurred. All four patients who relapsed in the spine had received local radiotherapy and had elevated serum and CSF‐AFP at baseline. All three patients with ventricular relapse received local radiation therapy.ConclusionsNGGCT patients continue to relapse beyond 5 years. Late ventricular relapse occurred even in patients without clear evidence of germinoma component. Elevated CSF‐AFP at diagnosis is associated with poor DFS and risk for distant CNS relapse. Patients with residual radiographic disease after chemotherapy or residual malignant histologies after second‐look surgery have inferior outcomes. Our data support consideration of treatment intensification for these patients.
End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School
Onuigbo, Macaulay

Healthcare | July 11, 2017 | Volume: 5 | Issue: 3 | Pages: 31

10.3390/healthcare5030031 Get It

Renal transplantation is the sine qua non consummate form of renal replacement therapy (RRT) for end stage renal disease (ESRD). Despite the increasing ESRD burden worldwide, developing countries continue to experience a gross lack of RRT options for its teeming citizens with ESRD. This report is a demonstration of a nephrologist’s experience and dilemma trying to make sense of the yawning disparity between RRT options, especially renal transplantation, as it applies to the citizens of the USA versus the citizens of Nigeria. The limited three-year experience of renal transplantation at Garki Hospital, located in Abuja, the capital of Nigeria, which is one of the very few centers carrying out renal transplantation in Nigeria, was starkly contrasted with this author’s first-hand experience at the University of Maryland Medical School, in Baltimore, Maryland, USA, as a Nephrology Fellow between 2000 and 2002. The potential role of public-private partnership (PPP) ventures in developing countries is considered as a way to help bridge this gap.
Author response: Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response
Chen, Xiaoli , Liu, Qiuying , Zhang, Xu , Zhang, Shaojie , Hu, Wenqian

No container title available | July 11, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.27786.024 Get It

Response to: Mesenchymal Stem Cells: Time to Change the Name!
Windt, Tommy S. de , Vonk, Luciënne A. , Saris, Daniël B.F. , de Windt, Tommy S , Vonk, Lucienne A

Stem Cells Translational Medicine | July 11, 2017 | Volume: 6 | Issue: 8 | Pages: 1747-1748

10.1002/sctm.17-0120 | PMID 28696033 Get It

Frequent loss of inositol polyphosphate‐5‐phosphatase in oropharyngeal squamous cell carcinoma
Patel, Amisha , Mangold, Aaron R. , Costello, Collin M. , Nagel, Thomas H. , Hayden, Richard E. , Sekulić, Aleksandar , Smith, Maxwell L. , Mangold, A R , Costello, Collin M

Journal of the European Academy of Dermatology and Venereology | July 11, 2017 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/jdv.14462 | PMID 28696004 Get It

Single‐center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area
Lohrmann, Graham , Vucicevic, D., Lawrence, Romy, Steidley, D. Eric , Scott, Robert L. , Kusne, Shimon , Blair, Janis E. , Lohrmann, Graham M, Vucicevic, Darko

Transplant Infectious Disease | July 11, 2017 | Volume: 19 | Issue: 5 | Pages: No page available

10.1111/tid.12744 | PMID 28695649 Get It

AbstractIn endemic regions, coccidioidomycosis causes substantial morbidity and mortality for patients receiving solid organ transplants. We aimed to demonstrate the effect of antifungal coccidioidal prophylaxis in heart transplant (HT) recipients. We retrospectively reviewed the electronic health records of all patients who received HTs between October 19, 2005, and December 13, 2014. We collected information regarding antifungal regimens and determined whether patients subsequently developed infections. Our 174‐person cohort all received antifungal prophylaxis for at least 6 months (mean follow‐up, 53.8 months). One proven and one probable coccidioidal infection (each, 0.6%) occurred during the study period. The incidence of coccidioidomycosis was 0.6% at 1 year and 2.3% at 5 years. No cases of proven coccidioidomycosis occurred within 2 years after transplantation. No patients developed disseminated disease, and no sentinel events were attributed to coccidioidomycosis. Both fluconazole and voriconazole were well tolerated. In the absence of intolerance or contraindication, we suggest continuing a universal antifungal prophylactic regimen with fluconazole for at least 6‐12 months in HT recipients residing in a coccidioidomycosis‐endemic area.
HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry
Henriksen, Eva , Viken, Marte K. , Wittig, Michael , Holm, Kristian , Folseraas, Trine , Mucha, Sören , Melum, Espen , Hov, Johannes R. , Lazaridis, K.N., Juran, Brian D., Chazouillères, O., Färkkilâ, Martti , Gotthardt, Daniel , Carbone, Marco , Hirschfield, Gideon M. , Rushbrook, Simon, Goode, Elizabeth C. , Ponsioen, Cyriel Y. , Weersma, Rinse K. , Eksteen, Bertus , Yimam, Kidist, Goldberg, David S. , Yu, Leonard T., Bowlus, Christopher L. , Lie, Benedicte A. , Karlsen, Tom H. , Henriksen, E K K , Viken, M K , Invernizzi, Pietro , Gordon, Stuart C. , Franke, André , Bowlus, Christopher L , Carbone, Marco , Hirschfield, Gideon M , Hov, Johannes R

HLA | July 11, 2017 | Volume: 90 | Issue: 4 | Pages: 228-233

10.1111/tan.13076 | PMID 28695657 Get It

Primary sclerosing cholangitis (PSC) is strongly associated with several human leukocyte antigen (HLA) haplotypes. Due to extensive linkage disequilibrium and multiple polymorphic candidate genes in the HLA complex, identifying the alleles responsible for these associations has proven difficult. We aimed to evaluate whether studying populations of admixed or non‐European descent could help in defining the causative HLA alleles. When assessing haplotypes carrying HLA‐DRB1*13:01 (hypothesized to specifically increase the susceptibility to chronic cholangitis), we observed that every haplotype in the Scandinavian PSC population carried HLA‐DQB1*06:03. In contrast, only 65% of HLA‐DRB1*13:01 haplotypes in an admixed/non‐European PSC population carried this allele, suggesting that further assessments of the PSC‐associated haplotype HLA‐DRB1*13:01‐DQA1*01:03‐DQB1*06:03 in admixed or multi‐ethnic populations could aid in identifying the causative allele.
Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments
Master, Zubin , Fu, Wayne , Paciulli, Danielle, Sipp, Douglas , Master, Zubin

Clinical Pharmacology & Therapeutics | July 11, 2017 | Volume: 102 | Issue: 2 | Pages: 177-179

10.1002/cpt.704 | PMID 28695633 Get It

The direct‐to‐consumer marketing of unproven stem cell interventions (SCIs) is a serious public health concern. Regulations and education have had modest impact, indicating that different actors must play a role to stop this unfettered market. We consider the role of the biotech industry in tackling unproven SCIs. Grounded in the concept of corporate social responsibility, we argue that biotech companies should screen consumers to ensure that products and services are being used appropriately and educate employees about unproven SCIs.